Filing Details

Accession Number:
0001181431-11-047038
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-25 17:56:39
Reporting Period:
2011-08-23
Filing Date:
2011-08-25
Accepted Time:
2011-08-25 17:56:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1444683 Jatin Shah C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Sr Vp & Chief Scientific Offic No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-08-24 2,000 $92.16 2,477 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Right to Buy Acquisiton 2011-08-23 1,074 $0.00 1,074 $90.65
Common Stock Employee Stock Option Right to Buy Acquisiton 2011-08-23 1,073 $0.00 1,073 $90.65
Common Stock Employee Stock Option Right to Buy Acquisiton 2011-08-23 1,073 $0.00 1,073 $90.65
Common Stock Restricted Stock Units Acquisiton 2011-08-23 794 $0.00 794 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,074 2012-08-23 2021-08-23 No 4 A Direct
1,073 2013-08-23 2021-08-23 No 4 A Direct
1,073 2014-08-23 2021-08-23 No 4 A Direct
794 2014-08-23 2014-08-23 No 4 A Direct
Footnotes
  1. Each Restricted Stock Unit represents a contingent right to receive one share of Perrigo Company common stock.
  2. Restricted Stock Units awarded Mr. Shah in his capacity as Sr. Vice President and Chief Scientific Officer, pursuant to the 2008 Long-Term Incentive Plan.
  3. The price in column 4 is a weighted average. The prices actually received ranged from $92.12 to $92.21. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.